| Patents for C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718) |
|---|
| 03/20/2003 | US20030054028 Sustained releasing drug in situ |
| 03/19/2003 | CN1404482A Pteridine compounds for the treatment of psoriasis |
| 03/18/2003 | CA2190588C Pteridine nucleotide analogs as fluorescent dna probes |
| 03/14/2003 | WO2002023991A1 Use of riboflavin and flavin derivatives as chitinase inhibitors |
| 03/14/2003 | CA2422584A1 Use of riboflavin and flavin derivatives as chitinase inhibitors |
| 03/13/2003 | WO2003020722A1 Novel dihydropteridinones, method for producing the same and the use thereof as medicaments |
| 03/12/2003 | EP1289521A2 Combination of lipoic acid and c 1 donors for the treatment of disorders of the central nervous system |
| 03/05/2003 | EP1288205A1 Novel phenylalanine derivatives |
| 03/05/2003 | EP1286704A2 Ethylenedicysteine (ec)-drug conjugates |
| 03/05/2003 | CN1400973A Novel biarylcarboxamides |
| 02/26/2003 | EP1284730A1 Aralkyl ester soft drugs |
| 02/26/2003 | CN1399561A Conjugate having cleavable linkage for use in liposome |
| 02/18/2003 | WO2002016329A1 Novel phenylalanine derivatives |
| 02/12/2003 | EP1282366A2 Compositions containing folic acid and reduced folate |
| 02/12/2003 | CN1396198A Bulk coloured high polymer organic material containing pyrimido-pteridine or its mixture |
| 02/11/2003 | CA2205274C Novel 2,3 disubstituted-(5,6)-heteroarylfused-pyrimidine-4-ones |
| 01/30/2003 | WO2003007961A1 Methods for treating neoplastic, angiogenic, fibroplastic, and/or immunosuppresive ocular irregularities via administration of methotrexate based medicaments, and ocular iontophoretic devices for delivering methotrexate based medicaments |
| 01/30/2003 | US20030023104 For prolonging or altering the activity of a compound which is a member of the chlorambucil family |
| 01/23/2003 | US20030017166 Combination preparation for the therapy of immunological diseases |
| 01/15/2003 | EP1275638A1 Combination therapy for the treatment of immunological disorders |
| 01/15/2003 | EP1275393A1 Pharmaceutical formulation containing pteridine derivative |
| 01/14/2003 | US6506762 Certain alkylene diamine-substituted heterocycles |
| 01/09/2003 | WO2003002713A2 Antibodies to opgl |
| 01/09/2003 | WO2003002064A2 Fused pyrimidine dhfr inhibitors as antibacterials |
| 01/09/2003 | WO2003001887A2 Fused pyrimidines as d-alanyl-d-alanine ligase inhibitors |
| 01/09/2003 | US20030008867 Compounds |
| 01/09/2003 | CA2451955A1 Antibodies to opgl |
| 01/09/2003 | CA2451840A1 Fused pyrimidine dhfr inhibitors as antibacterials |
| 01/09/2003 | CA2451800A1 Fused pyrimidines as d-alanyl-d-alanine ligase inhibitors |
| 01/06/2003 | CA2392187A1 Combination preparation for the therapy of immunological diseases |
| 12/31/2002 | US6500829 Mixtures of stereoisomers used as anticarcinogenic agents or for the treatment of vitamin deficiency |
| 12/26/2002 | US20020198212 Optically active compounds |
| 12/17/2002 | CA2053826C Pharmaceutical compositions active in the therapy of neurological affections in aids patients |
| 12/11/2002 | EP1100805B1 Medicine nitrate salts |
| 12/05/2002 | US20020183385 Administering a therapeutically effective amount of arsenic compounds to a mammal for treating solid tumor |
| 11/28/2002 | WO2002094185A2 Conjugates and compositions for cellular delivery |
| 11/28/2002 | CA2447161A1 Conjugates and compositions for cellular delivery |
| 11/27/2002 | EP1259512A1 Pteridine compounds for the treatment of psoriasis |
| 11/27/2002 | EP1259508A1 Novel biarylcarboxamides |
| 11/20/2002 | EP0892780B1 M-AMIDINO PHENYL ANALOGS AS FACTOR Xa INHIBITORS |
| 11/13/2002 | EP1255750A1 INDOLE AND BENZIMIDAZOLE INHIBITORS OF FACTOR Xa |
| 11/07/2002 | US20020165241 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate (NMDA) |
| 11/07/2002 | US20020165202 Antiinflammatory agents; antiproliferative agents |
| 11/06/2002 | WO2001084962A2 Compositions containing folic acid and reduced folate |
| 11/06/2002 | CA2408401A1 Compositions containing folic acid and reduced folate |
| 11/05/2002 | US6476040 Processes and intermediates for preparing anti-cancer compounds |
| 10/31/2002 | WO2002085908A1 Folate mimetics and folate-receptor binding conjugates thereof |
| 10/30/2002 | CN1377356A Certain alkylene diamine-substituted heterocycles |
| 10/23/2002 | EP1250315A1 Functional monomers for molecular recognition and catalysis |
| 10/17/2002 | WO2002081455A1 Process for coupling amino acids to an antifolate scaffold |
| 10/17/2002 | US20020150601 Topical applying |
| 10/16/2002 | EP0802731B1 Prophylactic treatment of allergic contact dermatitis |
| 10/09/2002 | CN1373763A Pteridinones and kinase inhibitors |
| 10/03/2002 | WO2002076985A1 Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases |
| 09/25/2002 | EP0968179B1 N-sulphonyl and n-sulphinyl amino acid amides as microbiocides |
| 09/12/2002 | US20020128294 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 09/12/2002 | US20020128195 Hydrophilic polymer covalently and reversibly linked to amine-containing ligand through dithiobenzyl linkage; improves blood circulation time |
| 09/06/2002 | WO2002068409A1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 09/06/2002 | WO2002008475A3 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching |
| 09/06/2002 | CA2438895A1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 09/04/2002 | EP1235618A2 Bioconjugation in vivo to pulmonary or blood components |
| 09/04/2002 | EP0760664B1 Use of pteridine derivatives as no-synthase inhibitors |
| 09/04/2002 | CN1367169A Substituted 6,6-Hetero-dicycloderivative |
| 08/29/2002 | WO2001091807A3 Ethylenedicysteine (ec)-drug conjugates |
| 08/27/2002 | US6441168 Stable crystalline salts of 5-methyltetrahydrofolic acid |
| 08/22/2002 | US20020115595 Bioactive agent is covalently conjugated to an organocobalt complex's cobalt atom through a non-reactive atom in the bioactive agent molecule such as peptide, protein, nucleic acid and analogues |
| 08/20/2002 | US6436949 Heterocyclically substituted benzamides and their use |
| 08/15/2002 | WO2002062750A1 Cannabinoid receptor ligands |
| 08/15/2002 | US20020111294 Administering an organocobalt complex |
| 08/14/2002 | CN1364090A Medicinal compositions containing anti-Fas antibody |
| 08/07/2002 | EP1228080A2 Compositions and methods for double-targeting virus infections and targeting cancer cells |
| 08/01/2002 | US20020103212 Pharmaceutical compositions containing anti-fas antibody |
| 07/30/2002 | US6426415 Polyadenosine 5'-diphospho-ribose polymerase (parp) enzyme inhibitors, alkoxy substituted n-heterocycle derivatives |
| 07/24/2002 | EP1224187A2 Certain alkylene diamine-substituted heterocycles |
| 07/24/2002 | CN1360587A Method for producing by stereospecific hydration tetrahydropterins and optical pure derivs., in particular tetrahydrofolic acid and its optically pure derivs. |
| 07/24/2002 | CN1360586A Method for making pure stereoisomers of tetrahydrofolic acid ester salts and tetrahydrofolic acid by fractionated crystallisation of tetrahydrofolic acid salts |
| 07/17/2002 | EP1221982A1 Isoalloxazine derivatives to neutralize biological contaminants |
| 07/17/2002 | EP0801568B1 Compounds for inhibition of ceramide-mediated signal transduction |
| 07/11/2002 | WO2001017568A3 Bioconjugation in vivo to pulmonary or blood components |
| 07/09/2002 | US6417205 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 06/27/2002 | WO2002022602A3 Triazole compounds useful as protein kinase inhibitors |
| 06/27/2002 | US20020082261 Prophylactic or therapeutic agents for diseases haivng vascular dysfunction associated with insulin resistance |
| 06/26/2002 | EP1216246A1 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent |
| 06/26/2002 | CN1355713A Releasable bond and composition containing said bond |
| 06/25/2002 | US6410535 Prophylactic or therapeutic agents for diseases having vascular dysfunction associated with insulin resistance |
| 06/20/2002 | DE10062401A1 Verwendung von Folsäure und/oder deren Derivaten zur Herstellung kosmetischer oder dermatologischer Zubereitungen zur Prophylaxe von Schäden an der hauteigenen DNA und/oder zur Reparatur bereits eingetretener Schäden an der hauteigenen DNA Use of folic acid and / or derivatives thereof for producing cosmetic or dermatological preparations for the prevention of damage to the skin's DNA and / or repair of already occurred damage to the skin's DNA |
| 06/19/2002 | EP1214927A1 Use of folic acid and/or its derivatives for the manufacture of topical compositions |
| 06/19/2002 | CN1354640A Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
| 06/18/2002 | US6407116 2,4-dioxo-1,2,3,4-tetrahydroquinazoline derivatives; antiallergens, antiasthmatics, antihistamines, and antiinflammatory agents |
| 06/13/2002 | US20020072530 Indole and benzimidazole inhibitors of factor Xa |
| 06/12/2002 | EP1212120A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents |
| 06/06/2002 | WO2001093841A3 Barbituric acid analogs as therapeutic agents |
| 06/05/2002 | EP0722731B1 Remedy for spinocerebellar degeneration |
| 06/04/2002 | US6399609 Corticotropin releasing factor (crf) antagonists |
| 05/29/2002 | CN1351604A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 05/28/2002 | US6395724 Multibinding inhibitors of cyclooxygenase-2 |
| 05/22/2002 | CN1085230C Process for colouring high molecular weight organic material and polycyclic pigments |
| 05/15/2002 | EP1049694B1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines |
| 05/10/2002 | WO2001023389A3 Certain alkylene diamine-substituted heterocycles |
| 05/08/2002 | EP1202736A1 Nicotine in therapeutic angiogenesis and vasculogenesis |